66/100BKimberly-Clark stock forecast 2026–2029
Analysts' average 12-month price target for Kimberly-Clark is 114.20, 5.3% above the current price of 108.45. Their targets range from 105.00 to 120.00.
Of the 11 firms that rated Kimberly-Clark in the past 12 months, 3 rate it buy or strong buy, 7 hold and 1 sell or strong sell (each firm at its latest rating): a Hold consensus.
Analysts' 1-year price targets range from 105.00 to 120.00, with an average of 114.20.
| Strong buy | 0 | |
| Buy | 3 | |
| Hold | 7 | |
| Sell | 1 | |
| Strong sell | 0 |
12-month price target
| Highest target | 120.00 |
| Average target | 114.20 |
| Lowest target | 105.00 |
| Current price | 108.45 |
Kimberly-Clark price target history
Have analysts recently raised or lowered their Kimberly-Clark price target and rating?
How analysts rate Kimberly-Clark, month by month
3 of 11 firms rate it buy now, against 3 of 12 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Kimberly-Clark analyst upgrades, downgrades and price targets
The latest rating change came on 13 November 2025, when Argus Research upgraded Kimberly-Clark from Hold to Buy. The most recent new target came from UBS on 28 October 2026: 113.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 28 Oct 2026 | UBS Peter Grom | Reiterated · Neutral | 116.00 → 113.00 | -2.6% | 109.10 |
| 23 Oct 2026 | Canaccord Genuity | — | 105.00 | — | 112.32 |
| 25 Sept 2026 | Guggenheim | — | 120.00 | — | 97.22 |
| 11 Sept 2026 | Piper Sandler | Reiterated · Overweight | 121.00 → 118.00 | -2.5% | 98.48 |
| 5 Aug 2026 | UBS Peter Grom | Reiterated · Neutral | 115.00 → 116.00 | +0.9% | 110.11 |
| 21 Jul 2026 | Barclays | Reiterated · Equal Weight | 99.00 → 115.00 | +16.2% | 108.48 |
| 16 Jul 2026 | UBS | Reiterated · Neutral | 106.00 → 115.00 | +8.5% | 108.13 |
| 17 Jun 2026 | Piper Sandler | Reiterated · Overweight | 145.00 → 121.00 | -16.6% | 104.28 |
| 29 Apr 2026 | UBS | Reiterated · Neutral | 110.00 → 106.00 | -3.6% | 97.40 |
| 14 Apr 2026 | Barclays Lauren Lieberman | Reiterated · Equal Weight | 102.00 → 99.00 | -2.9% | 97.10 |
| 8 Apr 2026 | Wells Fargo | Reiterated · Equal Weight | 110.00 → 100.00 | -9.1% | 97.00 |
| 17 Feb 2026 | Wells Fargo | — | 105.00 → 110.00 | +4.8% | 109.41 |
| 28 Jan 2026 | UBS Peter Grom | Reiterated · Neutral | 107.00 → 110.00 | +2.8% | 100.51 |
| 16 Jan 2026 | Barclays | — | 132.00 → 102.00 | -22.7% | 99.64 |
| 14 Jan 2026 | UBS | Reiterated · Neutral | 130.00 → 107.00 | -17.7% | 98.86 |
| 5 Jan 2026 | Wells Fargo | Reiterated · Equal Weight | 140.00 → 105.00 | -25.0% | 98.52 |
| 1 Dec 2025 | BNP Paribas | Reiterated · Neutral | 110.00 | — | 109.84 |
| 13 Nov 2025 | Argus Research | Upgraded · Hold → Buy | — | — | — |
Kimberly-Clark EPS and revenue estimates
Analysts expect Kimberly-Clark's EPS to grow 10.4% a year until 2027. Over the last 5 years it fell 2.4% a year, and over the last 3 years it grew 2.0%.
Analysts expect Kimberly-Clark's revenue to grow 0.4% a year until 2028. Over the last 5 years it fell 2.1% a year, and over the last 3 years it fell 5.1%.
Revenue
EPS
Does Kimberly-Clark beat earnings estimates?
On average, analysts' EPS estimate was 7.3% off the result, either way, and their revenue estimate 2.2%, over the last 12 quarters.
- EPS beats
- 88 / 136
- Revenue beats
- 82 / 120
- Average EPS surprise, last 12
- +5.1%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 5 Nov 2026 | 1.65 | 1.70 | +3.0% | 4.13B | 4.13B | +0.2% |
| Q2 FY2026 | 4 Aug 2026 | 2.01 | 1.80 | -10.4% | 4.22B | 4.19B | -0.8% |
| Q1 FY2026 | 28 Apr 2026 | 1.93 | 1.97 | +2.1% | 4.09B | 4.16B | +1.9% |
| Q4 FY2025 | 27 Jan 2026 | 1.81 | 1.86 | +2.8% | 4.09B | 4.08B | -0.3% |
| Q3 FY2025 | 30 Oct 2025 | 1.75 | 1.82 | +4.0% | 4.09B | 4.13B | +0.9% |
| Q2 FY2025 | 1 Aug 2025 | 1.67 | 1.92 | +15.0% | 4.85B | 4.16B | -14.1% |
| Q1 FY2025 | 22 Apr 2025 | 1.89 | 1.93 | +2.1% | 4.89B | 4.84B | -1.1% |
| Q4 FY2024 | 28 Jan 2025 | 1.51 | 1.50 | -0.7% | 4.86B | 4.93B | +1.5% |
| Q3 FY2024 | 22 Oct 2024 | 1.70 | 1.83 | +7.6% | 5.06B | 4.95B | -2.1% |
| Q2 FY2024 | 23 Jul 2024 | 1.71 | 1.96 | +14.6% | 5.10B | 5.03B | -1.3% |
| Q1 FY2024 | 23 Apr 2024 | 1.63 | 2.01 | +23.3% | 5.08B | 5.15B | +1.3% |
| Q4 FY2023 | 24 Jan 2024 | 1.54 | 1.51 | -1.9% | 4.98B | 4.97B | -0.3% |
Kimberly-Clark stock price 2026–2029: scenarios
If Kimberly-Clark's earnings keep growing at the -0.9% a year analysts expect to FY2027, it would earn about 7.26 a share in FY2029. At the P/E it has traded at over the last five years (16.6 to 26.6) that is 120.40 to 192.76 a share, or 155.95 at its average P/E of 21.5. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 7.41 | 122.88 | 159.15 | 196.72 |
| FY2027 | 7.39 | 122.66 | 158.86 | 196.36 |
| FY2028 (extrapolated) | 7.32 | 121.52 | 157.40 | 194.55 |
| FY2029 (extrapolated) | 7.26 | 120.40 | 155.95 | 192.76 |
Each year's EPS is the analysts' consensus to FY2027; the years after continue its -0.9% a year. Bear, base and bull apply the lowest, average and highest P/E of the last five fiscal year ends (16.6, 21.5, 26.6).
Is Kimberly-Clark stock undervalued or overvalued?
Kimberly-Clark's P/E of 10.9 is near the bottom of its 5-year range (10.9 to 27.6, median 22.4). It is within 5% of its 5-year low. Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level. At its usual P/E (22.4 × EPS of 8.98), Kimberly-Clark's fair value is 201.41; the price, 108.45, is 46.2% below it. The EPS is without 0.95 a share of one-off gains in its other income, which the business does not repeat. Its forward P/E, on the consensus for FY2026, is 14.6.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (12.1 and 27.6). The price against its P/E range
- Price to earnings ratio (TTM)
- 10.92
- Five-year median P/E
- 22.42
- Five-year P/E range
- 10.9 – 27.6
- Forward P/E (FY2026)
- 14.64
- To the average target
- +5.3%
Most undervalued US stocks
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 195.09146Price 99.09244 | +96.9% | |
| 186.680 | 359.93270Price 186.68450 | +92.8% | |
| 213.670 | 405.66304Price 213.67507 | +89.9% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 42.225 | 79.0244Price 42.23157 | +87.1% | |
| 160.650 | 299.85225Price 160.65375 | +86.6% |
Furthest below the fair value on each stock's page, updated every day.